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Two RNA stem-loop structures in the gag gene have been implicated as representing the primary encapsidation
(packaging) signal for bovine leukemia virus (BLV), a member of the Deltaretrovirus of the Retroviridae. In this study, we
conducted an analysis of these RNA structures, stem loop 1 (SL1) and stem loop 2 (SL2), to determine if both the loop and
the stem nucleotide bases are important for RNA encapsidation. We have found that the primary sequence of the unpaired
bases located in the loop regions of both SL1 and SL2 are important for efficient RNA encapsidation and virus replication.
The primary sequence of the bases that form the stems for both SL1 and SL2 was observed to aid in efficient encapsidation
and replication. We also observed that the order of SL1 and SL2 is important for RNA encapsidation and virus replication
efficiency. A viral RNA with two copies of either SL1 or SL2 was found to replicate and package RNA as efficiently as a viral
RNA with only one copy of SL1 or SL2. This provides evidence that SL1 and SL2 are not functionally equivalent. Sequences
from human T cell leukemia virus type 1 (HTLV-1) that are located in the same region of HTLV-1 as the SL1 and SL2 of BLV
were used to replace the BLV SL1, SL2, or both in a BLV RNA. These BLV RNAs were still encapsidated and replicated,
suggesting that these sequences may function as an encapsidation signal in HTLV-1. The chimeric RNAs did not replicate as
well as the parental, indicating that the primary nucleotide sequence along with the secondary and tertiary structure of theINTRODUCTION
The RNA encapsidation (packaging) process for retro-
viruses is initiated by a recognition event of the genome
length viral RNA by the viral Gag polyprotein (for a recent
review, see Jewell and Mansky, 2000). The underlying
mechanisms for this recognition event are not clearly
understood. However, biochemical and genetic analyses
have indicated that this event involves the interaction
between stable RNA secondary structures at the 5 end
of the viral genome and, in many cases, amino acids in
the nucleocapsid domain of the Gag protein (Amaras-
inghe et al., 2001; Banks and Linial, 2000; Berkowitz et al.,
1995; Certo et al., 1998, 1999; De Guzman et al., 1998;
D’Souza et al., 2001; Gorelick et al., 1993; Harrison et al.,
1998; McBride and Panganiban, 1996, 1997; Poon et al.,
1998; Schmalzbauer et al., 1996; Schwartz et al., 1997).
These interactions are generally thought to be virus
specific, but there is evidence that cross- or copackaging
of retroviral RNAs by the Gag protein from another ret-
rovirus can occur (Browning et al., 2001). Recent evi-
dence strongly suggests that RNA is a structural element
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Molecular Virology, Immunology, and Medi-in retrovirus particles (Muriaux et al., 2001). Other RNA
viruses, such as coronaviruses, influenza virus, and he-
padnaviruses, also have RNA packaging signals that
involve stable RNA secondary structures (Cologna and
Hogue, 2000; Fosmire et al., 1992; Narayanan and
Makino, 2001; Pollack and Ganem, 1993; Tchatalbachev
et al., 2001). The diversity of mechanisms used by RNA
viruses to package viral RNA into particles remains to be
elucidated.
The encapsidation signal region of bovine leukemia
virus (BLV) was initially mapped by deletion analysis
(Mansky et al., 1995). The efficiency of RNA encapsida-
tion revealed two important regions. The first region
includes sequences downstream of the primer binding
site and near the gag gene start codon and was found to
be essential for RNA encapsidation. The second region
was a 132-nucleotide base sequence within the gag
gene that facilitates efficient RNA encapsidation in the
presence of the first region. These results led to the
conclusion that the encapsidation signal necessary for
efficient RNA packaging and virus production is discon-
tinuous (Mansky et al., 1995).
Further analysis has provided genetic evidence that
the primary encapsidation signal region of BLV consists
of two stable RNA stem-loop structures. These are lo-RNA plays a role in efficient RNA encapsidation and replic
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and virus production (Mansky and Wisniewski, 1998). A
secondary encapsidation signal that consists of one sta-
ble stem-loop structure was characterized in the capsid
domain of Gag. Interestingly, it was observed that the
predicted encapsidation signal region of either HTLV-1 or
HTLV-2 can replace a similar region spanning the BLV
primary encapsidation signal region and lead to replica-
tion of the chimeric virus.
In this study, we have conducted a structure and func-
tion analysis of the BLV SL1 and SL2. We have found that
the primary sequence of both the loop and the stem
sequences of SL1 and SL2 contribute to the ability of SL1
and SL2 to function as an encapsidation signal and allow
for efficient virus production. It was observed that the
order of SL1 and SL2 in BLV RNA was important and that
a second copy of either stem loop did not replace the
function of the stem loop that was deleted. Specific
replacement of SL1, SL2, or both SL1 and SL2 with
sequences from HTLV-1 allowed for encapsidation and
virus production of the chimeric viruses, suggesting that
these HTLV-1 sequences may act as an encapsidation
signal in HTLV-1 RNA. The chimeric BLV/HTLV-1 RNAs
did not replicate as well as the parental BLV RNA, indi-
cating that the primary nucleotide sequence as well as
the secondary and tertiary structure of the RNA can play
a role in efficient RNA encapsidation and replication.
RESULTS
Nucleotide bases in the loops of SL1 and SL2 are
important for efficient virus replication and RNA
encapsidation
To determine whether mutations in the loop bases of
SL1 and SL2 (Fig. 1A) would influence vector virus pro-
duction from FLK-BLV cells, mutants were constructed
that introduced mutations into of the loop of SL1 (mutant
634), SL2 (mutant 664), or both SL1 and SL2 (mutant
634/664). Each of the mutations introduced created a
SpeI restriction site in the mutant vector. Computer anal-
ysis of the mutant sequences indicated that SL1 and SL2
would form the same stable structures predicted with the
parental sequence. To test the ability of these vectors to
replicate, a BLV helper virus was used as described
under Materials and Methods. FLK-BLV cells were stably
transfected with each of the derivatives of pRW1. Com-
parable numbers of G418-resistant colonies were ob-
served for each mutant vector per microgram of trans-
fected plasmid DNA (data not shown). Approximately 100
G418-resistant colonies were pooled for each mutant
and used in parallel for cocultivation with MDBK target
cells.
Figure 2 shows the results of vector virus production
from FLK-BLV cells. The titers of the 634 and 664 mutants
indicate an approximate 10- to 7-fold reduction in virus
production relative to that of the parental RW1, respec-
tively. The amount of virus production for the double
mutant, 634/664, was approximately 50-fold lower than
RW1 (Fig. 2). The amount of virus production of 634/664
was comparable to that of 628/676 (Fig. 2), a previously
characterized mutant that contains nucleotide base
changes that disrupt both the SL1 and the SL2 stems
(Mansky and Wisniewski, 1998).
Analysis of viral RNA in the cytoplasm of virus-produc-
ing cells and in virus particles was done to determine if
the RNA encapsidation efficiency of the mutants corre-
lated with the reduction in virus production. The reduc-
tion in RNA packaging compared to that of the parental
RW1 for 634, 664, and 634/664 was 10-fold, 7-fold, and
over 50-fold, respectively (Fig. 3). These reductions in
RNA packaging correlate well with the observed reduc-
tions in virus production.
Base-switched mutant indicates that the primary
sequence of the stem nucleotide bases of SL1 and
SL2 are important for efficient RNA encapsidation
and replication
Previous data had provided an indication that the pri-
mary nucleotide base sequence of SL1 and SL2 was
important for RNA encapsidation and virus replication
(Mansky and Wisniewski, 1998). To address this further,
we constructed a “base-switched” mutant, RW1-bs (Fig.
1B), where the nucleotide bases in each stem loop were
switched to the other side of the stem. This caused the
new stem to become a mirror image of the original stem
relative to the loop nucleotide bases and the rest of the
viral RNA (Fig. 1). Since the interacting nucleotide bases
led to stem-loop structures that were comparable in
stability to the wild-type SL1 and SL2, it was predicted
that the same stem-loop structures would be as likely to
form as the wild-type. The base-switched mutations
were found to lead to a fivefold reduction in virus repli-
cation relative to that of the parental RW1 (Fig. 4). A
comparable reduction in RNA encapsidation was ob-
served with this mutant to that of the parent (Fig. 3). This
indicates that the primary sequence of the stem nucle-
otide bases of SL1 and SL2 is important for RNA encap-
sidation and virus replication.
Order of SL1 and SL2 is important for RNA
encapsidation and virus replication
To test whether the order of SL1 and SL2 in the viral
RNA was important, a mutant was created, RW1-2,1, in
which the order of SL1 and SL2 in the RNA was reversed
(Fig. 1B). The change in order of SL1 and SL2 led to a
threefold reduction in the amount of virus replication
compared to that of the parental vector (Fig. 4). It was
observed that this reduction in virus replication was
comparable to the level of reduction in RNA encapsida-
tion that was observed (Fig. 3), indicating that the reduc-
tion in virus replication was due to an RNA encapsidation
defect.
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FIG. 1. Location of mutations in stem loops 1 and 2 (SL1 and SL2) of the bovine leukemia virus (BLV) encapsidation signal and the predicted stable RNA
secondary structures for the RNA sequences used in replacement of the BLV SL1 and SL2 to create mutant derivatives. (A) Location of mutations in the BLV SL1
and SL2 RNA sequence made to create the 634 and 664 mutants. The numbering starts at the 5 end of the proviral DNA. The gag AUG are bases 628–630. The
mutated bases in each mutant vector virus, which created a SpeI restriction site in the proviral DNA, are shown below the wild-type BLV sequences. Bases that
are different from the wild-type bases are shown, and nonmutated bases are indicated by dots. The names of the mutant vectors are indicated below the mutant
sequences. (B) RNA secondary structures in mutant viruses that replace the BLV SL1 and SL2 in a BLV parental vector, RW1. RW1 contains the wild-type SL1 and
SL2 RNA sequence. The gag AUG is marked with a box. Paired bases are indicated with a dash (–) between the bases. The RNA structures in RW1 derivatives
with the order of the SL1 and SL2 switched (RW1-2,1) or with two copies of SL1 (RW1-1,1) or SL2 (RW1-2,2) are indicated. The RNA structures for the “base-switched”
mutant (RW1-bs) is shown and is described in Table 1 and in the text. The RNA structures in RW1 derivatives are shown in which SL1 was replaced by the human
T cell leukemia virus type 1 (HTLV-1) SL1 (RW1-HB), the BLV SL2 was replaced by the HTLV-1 SL2 (RW1-BH), and both SL1 and SL2 was replaced by the HTLV-1
SL1 and SL2. The wild-type HTLV-1 SL1 and SL2 together (wt HTLV-1) is also shown. The HTLV-1 gag AUG is marked with a box. The nucleotide numbering for
wt BLV and wt HTLV-1 is based on the complete BLV or HTLV-1 proviral DNA (Sagata et al., 1985; Seiki et al., 1983). Numbers alongside the RNA indicate the
coordinates relative to the proviral DNA.
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SL1 and SL2 are not functionally equivalent for virus
replication or RNA encapsidation
Previous data indicated that mutation of either SL1 or
SL2 led to an approximate 20-fold reduction in replication
and RNA encapsidation efficiencies (Mansky and
Wisniewski, 1998). To determine whether an RNA with
two copies of either SL1 or SL2 could replicate and
encapsidate RNA as efficiently as the parental vector
with one copy each of SL1 and SL2, mutants were con-
structed containing either two copies of SL1 (i.e., RW1-
1,1) or two copies of SL2 (i.e., RW1-2,2) (Fig. 1B). Repli-
cation in parallel with RW1 indicated that each mutant
replicated about fivefold lower than the parental vector
(Fig. 4). This indicated that SL1 and SL2 do not function
in an equivalent manner for virus replication. The two
RNA stem-loop structures were also not equal in function
for the encapsidation of viral RNA when two copies of
SL1 were present (Fig. 3). These results indicate that SL1
and SL2 are not functionally equivalent and serve spe-
cific roles in the RNA encapsidation process.
FIG. 1—Continued
FIG. 2. Nucleotide bases in the loops of SL1 and SL2 are important for efficient replication. The titer data presented are from three independent
experiments, where the relative titers (normalized to RW1) are presented as the average with the standard deviation indicated. The average absolute
titer of RW1 from these three experiments was 2  102 CFU/5  104 MDBK target cells. The 634, 664, and 634/664 mutants are described in Table
1. RW1 and 628/676 have been previously described (Mansky and Wisniewski, 1998).
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The predicted SL1 and SL2 from human T cell
leukemia virus (HTLV) can function as a RNA
encapsidation signal in BLV
The encapsidation signal region of BLV was previously
replaced with similar regions from either HTLV-1 or
HTLV-2 and shown that the resulting chimeric vectors
could replicate and encapsidate the chimeric RNA (Man-
sky and Wisniewski, 1998). This indicated a potential
conserved function in the RNA sequences from HTLV-1
and HTLV-2 that were introduced into RW1 in place of the
BLV encapsidation signal region. RNA secondary struc-
tures similar to the BLV SL1 and SL2 were predicted to
be directly downstream of the gag start codon of HTLV-1
and HTLV-2. Based on these observations, we directly
FIG. 3. Analysis of the relative cytoplasmic and virion RNA levels of SL1 and SL2 mutants. For analysis of viral RNA from the cytoplasm of
virus-producing cells, RNA from four petri dishes (100 mm) of infected or uninfected cells was twofold serially diluted and blotted onto nitrocellulose
paper. For analysis of viral RNA from virus particles, RNA from the equivalent of the supernatant medium from 25 petri dishes (100 mm) (200 ml total)
was twofold serially diluted and blotted. The probe used was a randomly primed probe in the U5 region of the BLV long terminal repeat. “C” indicates
viral RNA analyzed from uninfected cells. Figure 1 and Table 1 give a description of RW1-HH, RW1-1,1, and RW1-bs. Table 1 provides a description
of the 634, 664, and 634/664 mutants.
FIG. 4. The order, copy number, and stem sequences of SL1 and SL2 are important for efficient replication. The titer data presented are from three
independent experiments, where the relative titers (normalized to RW1) are presented as the average with the standard deviation indicated. The
average absolute titer of RW1 from these three experiments was 2  102 CFU/5  104 MDBK target cells. RW1-2,1, RW1-1,1, RW1-2,2, and RW1-bs are
described in Fig. 1 and Table 1.
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tested whether the predicted SL1 and SL2 of HTLV-1
could functionally replace the BLV SL1 and SL2 in RW1
by specifically replacing the SL1 and/or SL2 nucleotide
base sequence with the HTLV-1 SL1 and/or SL2 se-
quence. This led to the creation of three RW1 derivatives
with the following stem-loop sequences: (1) HTLV-1 SL1
and BLV SL2 (RW1-HB); (2) BLV SL1 and HTLV-1 SL2
(RW1-BH); (3) HTLV-1 SL1 and SL2 (RW1-HH) (Fig. 1B).
These three chimeric viruses (i.e., RW1-HB, RW1-BH,
and RW1-HH) were replicated in parallel with the paren-
tal RW1. As indicated in Fig. 5, each of the chimeric
viruses were able to replicate, but at reduced levels
compared to that of RW1. The replication of RW1-HB,
RW1-BH, and RW1-HH was reduced from the parent by
twofold, threefold, and fivefold, respectively. RNA analy-
sis of RW1-HH revealed a threefold reduction in RNA
encapsidation efficiency (Fig. 3), indicating that the re-
duction in replication was primarily due to the encapsi-
dation defect, but that another replication defect(s) con-
tributed to the reduction in replication efficiency for this
mutant.
DISCUSSION
The primary encapsidation signal for BLV contains two
stable RNA stem-loop structures, SL1 and SL2. A series
of mutations were introduced into these structures to
show that they functioned in RNA encapsidation (Mansky
and Wisniewski, 1998). In this study, further mutations
were created to test whether the primary nucleotide
sequence in both the stem and the loop sequences of
SL1 and SL2 were important for efficient replication and
RNA encapsidation. The importance of the relative order
of SL1 and SL2 in BLV RNA, as well as the functional
equivalence of SL1 and SL2, was also analyzed. To test
for conservation of function of SL1 and SL2, the predicted
SL1 and SL2 stem-loop sequences from HTLV-1 were
introduced to specifically replace the BLV SL1 and SL2 in
a BLV vector.
Mutations of the loop sequence of SL1, SL2, or both
SL1 and SL2 (mutants 634, 664, and 634/664), resulted in
reductions of virus replication of 10-fold, 7-fold, and 50-
fold, respectively. This indicates that the loop bases are
important for efficient virus replication. Reductions in
RNA encapsidation efficiency correlated with the ob-
served reductions in virus replication. A mutant (RW1-bs)
was created in which the bases in the stems of both SL1
and SL2 were switched to the opposite side of their
respective stem (to create a mirror image of the stem in
relation to the loop bases). This base-switched mutant
replicated and encapsidated RNA at approximately one-
sixth that of the parental virus. This suggests that the
primary sequence of the stems was important, though
the topology of the structure and not the primary se-
quence could be responsible for the lower replication
and RNA encapsidation efficiencies. Analysis of several
mutants (i.e., RW1-2,1, RW1-1,1, and RW1-2,2) indicated
that the order of SL1 and SL2 in BLV RNA was important
for function in replication and RNA encapsidation and
that SL1 and SL2 are not functionally equivalent.
Some of our observations are similar to what has been
observed with the two hairpin RNA secondary structures
of the spleen necrosis virus (SNV) encapsidation signal
(Yang and Temin, 1994). First, it was observed that the
two hairpins are not functionally equivalent. Second, a
base-switched mutant was tested and found to nega-
tively influence SNV replication. However, it was ob-
served that replacement of the two SNV hairpins with
those from murine leukemia virus (MLV) allowed for
efficient SNV replication. This suggests that the second-
ary or tertiary structures may play a greater role in RNA
packaging than the primary nucleotide sequence, which
is limited between the SNV and MLV hairpin RNA se-
quences. Interestingly, it has been observed that the
introduction of the SNV hairpins into MLV does not allow
for encapsidation of the chimeric RNA into MLV particles
(Certo et al., 1998).
Previous studies with BLV have indicated that flanking
sequences with RNA stem-loop structures contribute to
RNA packaging (Mansky et al., 1995; Mansky and
Wisniewski, 1998). The contribution of flanking se-
quences or neighboring RNA stem-loop structures has
also been shown for other retroviruses such as MLV and
SNV (Mougel et al., 1996; Yang and Temin, 1994). In a
recent study, chimeric MLV/SNV packaging signals were
analyzed and it was concluded that the two hairpins,
while important for RNA packaging, are not the major
FIG. 5. Specific replacement of the bovine leukemia virus (BLV) SL1
and SL2 with the predicted SL1 and SL2 of human T cell leukemia virus
type 1 (HTLV-1) allows for replication of a BLV vector. The titer data
presented are from three independent experiments, where the relative
titers (normalized to RW1) are presented as the average with the
standard deviation indicated. The average absolute titer of RW1 from
these three experiments was 2  102 CFU/5  104 MDBK target cells.
Figure 1 and Table 1 provide a description of RW1-HB, RW1-BH, and
RW1-HH.
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motif responsible for the ability of MLV proteins to dis-
criminate between the MLV and SNV packaging signals
(Beasley and Hu, 2002). Flanking sequences were ana-
lyzed and were found to be associated with packaging
specificity. This suggests that MLV Gag recognizes mul-
tiple elements in the viral packaging signal, including the
hairpin structures and upstream flanking regions. Inter-
estingly, a recent cell-free binding study using purified
MLV nucleocapsid protein and short RNAs revealed that
the nucleocapsid protein bound with high affinity to an
RNA containing the two hairpins along with other flank-
ing sequences, but did not bind to an RNA with just the
two hairpins (D’Souza et al., 2001). Taken together, these
observations indicate that complex RNA–protein interac-
tions are involved in RNA packaging.
A previous study had proposed two RNA stem-loop
structures in the HTLV-1 genome as being the encapsida-
tion signal (i.e., SL1 and SL2) (Mansky and Wisniewski,
1998). As a partial test of this hypothesis, these RNA stem-
loop structures were used to specifically replace the BLV
SL1 and SL2 to determine if they could functionally replace
the BLV RNA stem-loop sequences. The chimeric vectors
replicated, but not at the level of the parental virus. How-
ever, the chimeric vectors with just one BLV RNA stem loop
replaced for an HTLV-1 stem loop sequence replicated with
higher efficiency than mutants where either the BLV SL1 or
the SL2 was mutated, leaving just one functional RNA
stem-loop in the vector (Mansky and Wisniewski, 1998). In
particular, the mutant 667, which has a functional SL1 but a
disrupted SL2, was found to replicate at one-tenth that of
the parental RW 1 (Mansky and Wisniewski, 1998), while
RW1-BH was able to replicate at one-third that of RW1. This
indicates that the predicted HTLV-1 SL2 can function, albeit
not as efficiently, as SL2 in BLV. The mutant 628, which has
a functional SL2 but a disrupted SL1, was also found to
replicate at one-tenth that of the parental RW 1 (Mansky
and Wisniewski, 1998), while RW1-HB was able to replicate
at one-half that of RW1. This indicates that the predicted
HTLV-1 SL1 can partially replace the function BLV SL1.
These observations suggest that the predicted SL1 and
SL2 of HTLV-1 function as the HTLV-1 encapsidation signal.
However, it is possible that the encapsidation signal in-
volves other sequences in the HTLV-1 genome and that the
primary sequence and predicted RNA secondary structures
are conserved for another function(s), such as encoding of
the matrix domain of the Gag polyprotein precursor. It is
interesting to note that the mutants 634 and 664, which had
nucleotide base changes in the loop bases of BLV SL1 and
SL2, respectively, had a greater effect on RNA packaging
than when the BLV stem loops were replaced with HTLV-1
stem loops. One interpretation of this data is that the loop
base changes altered the tertiary RNA structure or RNA–
protein interactions to a greater extent than the replace-
ment of the BLV stem loops with the corresponding HTLV-1
stem loops. Taken together, the chimeric BLV/HTLV-1 RNAs
did not replicate as well as the parental BLV RNA, indicating
that both the primary nucleotide sequence and the second-
ary and tertiary structure of the RNA can play a role in
efficient RNA encapsidation and replication.
MATERIALS AND METHODS
Computer analysis of viral RNA sequences
Calculation and analysis of minimal free energy and
suboptimal RNA secondary structures for wild-type and
mutant portions of the BLV and HTLV-1 RNA sequence
were done with the FOLDRNA (Zuker and Stiegler, 1981)
and MFOLD (Jaeger et al., 1989; Zuker, 1989) programs
within the GCG analysis package (version 8; Genetics
Computer Group, Madison, WI) (Devereux et al., 1984)
using the Turner energy tables (Freier et al., 1986).
The MFOLD program at the website of M. Zuker (http://
bioinfo.math.rpi.edu/zukerm/) was also used.
Construction of BLV vectors
The parental BLV vector used in this study was pRW 1
(Mansky and Wisniewski, 1998), which was derived from
pBLV-SVNEO (Derse and Martarano, 1990). The deriva-
tives of pRW 1 that were constructed to test the structure-
function relationship of the predicted loop structures in
SL1 and SL2 (i.e., mutants 634 and 644) were made using
a primary/combinatorial two-step PCR protocol (Ito et al.,
1991). The location of the mutations in SL1 and SL2 are
indicated in Fig. 1A. Each mutant resulted in the creation
of a SpeI site that could be used to help identify the
introduction of the desired mutations. BLV vectors that
contained SL1 and SL2 in reverse order contained two
copies of SL1, or contained the base-switched mutant
were also constructed by PCR mutagenesis (Fig. 1B).
PCR-amplified DNA was cloned into the BclI and SalI
sites of pRW1 (Mansky and Wisniewski, 1998). All mu-
tants made were sequenced to confirm the introduction
of the desired mutations. Chimeric BLV vectors contain-
ing the predicted SL1 and SL2 of HTLV-1 in place of the
BLV SL1 and SL2 (Fig. 1B) were made by PCR mutagen-
esis. The HTLV-1 sequence used as a template was
pHTLV-1-CMVneo (Copeland et al., 1994; Derse et al.,
2001; Seiki et al., 1983). DNA sequencing was done to
confirm the proper introduction of the HTLV-1 SL1 and
SL2 in place of the BLV SL1 and SL2. Computer analysis
was done for each mutant construct to verify that stable
RNA secondary structures were predicted which resem-
bled the anticipated RNA secondary structures. Table 1
provides a summary of the vector derivatives made from
the parental RW1.
Cell lines, transfections, and cocultivations
Fetal lamb kidney cells chronically infected with BLV
(FLK-BLV cells) were used to test for vector virus produc-
tion (Van der Maaten and Miller, 1976). FLK-BLV cells
produced all the BLV proteins necessary for virus pro-
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duction and have been used previously for vector virus
production. Madin–Darby bovine kidney (MDBK)-based
BLV helper cells (Mansky et al., 1995) were used to test
RNA encapsidation efficiencies of selected mutants. All
cells were grown in Dulbecco’s modified Eagle’s medium
supplemented with either 10% fetal bovine serum or 10%
Fetalclone III (HyClone, Logan, UT). MDBK-based BLV
helper cells and FLK-BLV cells were transfected with
SuperFect (Qiagen, Valencia, CA) according to the man-
ufacturer’s instructions.
FLK-BLV cells were transfected with each of the vec-
tors tested. Two days posttransfection, cells were placed
under G418 selection (900 g/ml). Approximately 100
G418-resistant colonies were pooled and used for cocul-
tivation with fresh MDBK target cells. Infection of target
cells was done by cocultivation of mitomycin C treated,
virus-producing cells with target cells as described by
Mansky and Temin, 1994. Typically, virus-producing cells
(about 2.5  105 cells per 60-mm petri dish) were treated
with mitomycin-C (10 g/ml), an inhibitor of host-cell
DNA synthesis, for 2 h at 37°C. The cells were then
washed three times with fresh medium, and 2.5  105
MDBK target cells were added. Two days after coculti-
vation, selective medium containing G418 was added.
Control experiments were done with each cocultivation
experiment to ensure that mitomycin C treated, virus-
producing cells did not proliferate and no longer adhered
to the surfaces of culture dishes (Mansky and Temin,
1994).
Viral RNA analysis
Selected derivatives of RW 1 were tested for RNA
encapsidation efficiencies. MDBK-based BLV helper
cells were transfected with selected vectors from the
replication experiments. Two days posttransfection, cells
were placed under G418 selection (1 mg/ml). Approxi-
mately 100 G418-resistant colonies were pooled and
used for cocultivation with fresh helper cells. Infection
was done by cocultivation of virus-producing cells with
fresh helper cells. Two days after cocultivation, selective
medium containing G418 was added. Control experi-
ments were done with each cocultivation experiment to
insure that mitomycin-C treated, virus-producing cells
did not proliferate and no longer adhered to the surfaces
of culture dishes (Mansky and Temin, 1994).
Levels of vector viral RNA in infected helper cells and
in virions produced from those cells were determined by
RNA slot blot analysis as previously described (Mansky
et al., 1995). Cytoplasmic RNA was harvested from pools
of G418-resistant clones that had been infected by cocul-
tivation with mutants of RW 1. Virion RNA was purified
from virions pelleted from cleared supernatant medium.
Cytoplasmic and virion RNAs were denatured at 65°C
for 15 min. Samples were twofold serially diluted in 20
SSC and were blotted onto nitrocellulose paper (Schlei-
cher & Schuell, Keene, NH) with a slot blot vacuum
manifold (Bio-Rad, Richmond, CA). The blots were then
baked under vacuum at 80°C for 2 h. A DNA probe
representing the U5 region of the 5 end of the viral RNA,
which is downstream from the splice donor site for the
env mRNA, was used for hybridizations. Results were
visualized, and relative intensities were quantified with a
Phosphoimager (Molecular Dynamics, Sunnyvale, CA).
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